Adam Torres and Debra Feinberg discuss advances in precision healthcare made by Human Longevity, Inc.
- Precision medicine
- Whole body imagery
- Blood biomarkers
- Measure what matters
Preventive healthcare has long been the goal of many. What if there was a new level of healthcare to aspire too? That is exactly what precision healthcare and “measuring what matters” aims to accomplish. In this episode Adam Torres and Debra Feinberg, VP of Marketing at Human Longevity, Inc., explore this new frontier of healthcare.
About Human Longevity, Inc.
Human Longevity, Inc. ™ (HLI) is the genomics-based, health intelligence company creating the world’s largest and most comprehensive database of whole genome, phenotype and clinical data. HLI is developing and applying large scale computing and machine learning to make novel discoveries from these data to generate personalized health insights. Our goal is to extend healthy human life by revolutionizing human health and transforming the practice of medicine.
Our DNA determines so much about each of us, but other factors can also influence our health. HLI is focused on compiling and analyzing more genotypic and phenotypic data because the combination of both enables us —to generate unprecedented insights and accelerate our understanding into what makes us who we are and what we can change for a life better lived.
Apply to be interviewed by Adam on one of our Podcasts
Submit application here: https://missionmatters.lpages.co/podcastguest/